InStem And Curie Institute Scientists Develop Molecular Sensor To Detect Cancer Drugs

Mumbai : The Institute for Stem Cell Science and Regenerative Medicine (InStem), Bengaluru in collaboration with Curie Institute, Orsay, France, has developed a molecular sensor, which can identify cancer drugs by detecting how such chemicals modify microtubules inside living cells.

Microtubules are part of the cytoskeleton, a structural network within the cell’s cytoplasm, and they alter in response to several chemicals.

“Understanding tubulin modifications have remained a challenge till date because of unavailability of tools that can mark them in living cells. Both the researchers have overcome this shortcoming and developed the first tubulin nanobody – or sensor to study the dynamics of microtubule modifications in living cells and use this for identification of new cancer therapeutic drugs”, said the statement issued by the Department of Science and Technology (DST).

The researchers from Bengaluru and Orsay devised a method to design synthetic proteins, known as nanobodies, which can bind specifically to modified microtubules. These nanobodies are similar to antibodies made in our body as a defense mechanism against pathogens. However, unlike antibodies, the nanobodies are smaller in size and easily amenable for protein engineering. The nanobody was then coupled with a fluorescent molecule to serve as a detection tool, called sensor. They developed and validated a live cell sensor against a unique microtubule modification called tyrosinated form of microtubules that is already known to be important for cell division and intracellular organization.

The tyrosination sensor is the first tubulin nanobody – or sensor – that can be used to study the dynamics of microtubule modifications in living cells. Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA) researchers has shown the application of this sensor in studying the effect of small-molecule compounds that target microtubules. These chemicals are frequently used as anti-cancer drugs. Thus, the tyrosination sensor will facilitate studying microtubule functions for many researchers and will aid identifying new drugs of therapeutic value.

  • Related Posts

    Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

    Green dot or red dot? Soaps, shampoos and toothpaste to reveal if they are veg or non-veg That green dot you usually look for on a food packet could soon…

    Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

    The Drugs Control Department has seized counterfeit rabies vaccine worth about ₹2 lakh from a firm in Chandni Chowk’s Bhagirath Palace, the Delhi government said on Tuesday. Health Minister Pankaj…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

    Green or red dot? Your soap, shampoo and toothpaste will now reveal if they’re veg or non-veg

    Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

    Counterfeit rabies vaccine worth ₹2 lakh seized in Delhi

    AIIA organises public awareness rally on 11th Ayurveda Day

    AIIA organises public awareness rally on 11th Ayurveda Day

    UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

    UKHSA and University of Oxford scientists uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

    ‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

    ‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs

    CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

    CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance